Suchergebnisse - "Ogata, Misato"

PubPharm (18)

1

A CASE OF EOSINOPHILIC GRANULOMATOUS WITH POLYANGIITIS WITH SKIN LESIONS ASSOCIATED WITH PSORIASIS

enthalten in: Arerugi = [Allergy | 2023

von Oshita, H. | Ogata, M. | Inoue, A. | +4

2

FREQUENCY OF IMAGING FINDINGS RESEMBLING MYCOBACTERIOSIS AND CHARACTERISTICS OF COMORBID PULMONARY NON-TUBERCULOSIS MYCOBACTERIOSIS IN THE PATIENTS WITH ALLERGIC BRONCHOPULMONARY MYCOSIS

enthalten in: Arerugi = [Allergy | 2023

von Oshita, H. | Ogata, M. | Inoue, A. | +4

3

Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Patients With Active Cancer

enthalten in: In vivo (Athens, Greece) | 2021

von Ogata, M. | Ama, Y. | Ogata, T. | +3

4

Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer : a real-world multi-centre cohort study in Japan (WJOG12519B)

enthalten in: Breast cancer (Tokyo, Japan) | 2021

von Yokoe, T. | Kurozumi, S. | Nozawa, K. | +22

5

Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B)

enthalten in: Breast cancer | 2021

von Yokoe, T. | Kurozumi, S. | Nozawa, K. | +22

6

Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B)

enthalten in: Breast cancer | 2021

von Yokoe, T. | Kurozumi, S. | Nozawa, K. | +22

7

Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B)

enthalten in: Breast cancer | 2021

von Yokoe, T. | Kurozumi, S. | Nozawa, K. | +22

8

Regorafenib vs trifluridine/tipiracil for metastatic colorectal cancer refractory to standard chemotherapies : A multicenter retrospective comparison study in Japan

enthalten in: PloS one | 2020

von Ogata, M. | Kotaka, M. | Ogata, T. | +5

9

Reduction and Escalation in the Dose of Sunitinib Were Adequately Effective against Gastrointestinal Stromal Tumor of the Small Intestine

enthalten in: Internal medicine (Tokyo, Japan) | 2019

von Ogata, M. | Satake, H. | Ogata, T. | +4

10

Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with ALK mutation

enthalten in: Internal medicine (Tokyo, Japan) | 2019

von Ogata, M. | Hatachi, Y. | Ogata, T. | +3